Atherosclerosis
Volume 220, Issue 2 , Pages 362-368, February 2012

Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice

  • Man C. Wong

      Affiliations

    • The Dept. of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • The Dept. of Pulmonology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author at: Leiden University Medical Center, Department of Pulmonology, Postzone: C3-P, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Tel.: +31 071 5262082; fax: +31 071 5266927.
  • ,
  • Janna A. van Diepen

      Affiliations

    • The Dept. of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Lihui Hu

      Affiliations

    • The Dept. of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Bruno Guigas

      Affiliations

    • The Dept. of Molecular Cell Biology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Hetty C. de Boer

      Affiliations

    • The Dept. of Nephrology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • The Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Gijs H. van Puijvelde

      Affiliations

    • Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, P.O. Box 9502, 2300 RA Leiden, The Netherlands
  • ,
  • Johan Kuiper

      Affiliations

    • Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, P.O. Box 9502, 2300 RA Leiden, The Netherlands
  • ,
  • Anton J. van Zonneveld

      Affiliations

    • The Dept. of Nephrology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • The Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Steven E. Shoelson

      Affiliations

    • Joslin Diabetes Center and the Dept. of Medicine, 1 Joslin Place, Boston, MA 02215, USA
  • ,
  • Peter J. Voshol

      Affiliations

    • The Dept. of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Present address: Metabolic Research Laboratories, Level 4, Institute of Metabolic Science, Box 289, Addenbrooke's Hospital Cambridge, CB2 0QQ, United Kingdom.
  • ,
  • Johannes A. Romijn

      Affiliations

    • The Dept. of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Present address: The Dept. of Internal Medicine, University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands.
  • ,
  • Louis M. Havekes

      Affiliations

    • The Dept. of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • The Dept. of Cardiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Netherlands Organization for Applied Scientific Research – Biosciences, Gaubius Laboratory, P.O. Box 2215, 2301 CE Leiden, The Netherlands
  • ,
  • Jouke T. Tamsma

      Affiliations

    • The Dept. of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Patrick C.N. Rensen

      Affiliations

    • The Dept. of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Pieter S. Hiemstra

      Affiliations

    • The Dept. of Pulmonology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Jimmy F.P. Berbée

      Affiliations

    • The Dept. of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • The Dept. of Experimental Immunohematology, Sanquin Research Amsterdam, P.O. Box 9190, 1006 AD Amsterdam, The Netherlands

Received 30 March 2011; received in revised form 3 June 2011; accepted 29 June 2011. published online 28 July 2011.

Abstract 

Objective

The liver is the key organ involved in systemic inflammation, but the relation between hepatic inflammation and atherogenesis is poorly understood. Since nuclear factor-κB (NF-κB) is a central regulator of inflammatory processes, we hypothesized that chronically enhanced hepatic NF-κB activation, through hepatocyte-specific expression of IκB kinase-β (IKKβ) (LIKK), will aggravate atherosclerosis development in APOE*3-Leiden (E3L) mice.

Methods and results

E3L.LIKK and E3L control littermates were fed a Western-type diet for 24 weeks. E3L.LIKK mice showed a 2.3-fold increased atherosclerotic lesion area and more advanced atherosclerosis in the aortic root with less segments without atherosclerotic lesions (11% vs. 42%), and more segments with mild (63% vs. 44%) and severe (26% vs. 14%) lesions. Expression of LIKK did not affect basal levels of inflammatory parameters, but plasma cytokine levels tended to be higher in E3L.LIKK mice after lipopolysaccharide (LPS) administration. E3L.LIKK mice showed transiently increased plasma cholesterol levels, confined to (V)LDL. This transient character resulted in a mild (+17%) increased cumulative plasma cholesterol exposure.

Conclusion

We conclude that selective activation of NF-κB in hepatocytes considerably promotes atherosclerosis development which is (at least partly) explained by an increased sensitivity to proinflammatory triggers and transiently increased plasma cholesterol levels.

Abbreviations: apoB, apolipoprotein B, CE, cholesteryl ester, Cpt1a, carnitine palmitoyltransferase 1a, cyclo, cyclophilin, E3L, APOE*3-Leiden, Fas, fatty acid synthase, FC, free cholesterol, FPLC, fast performance liquid chromatography, Gapdh, glyceraldehyde-3-phosphate dehydrogenase, Hmgcr, HMG-CoA reductase, Hprt, hypoxanthine-guanine phosphoribosyl transferase, HPS, hematoxylin–phloxine–saffron, IFNγ, interferon γ, IκB, inhibitor of κB, IKKβ, IκB kinase-β, IL-1β, interleukin-1β, IL-6, interleukin-6, IL-10, interleukin-10, IL-12p70, interleukin-12p70, LIKK, liver-specific IKKβ, MCP-1, monocyte chemoattractant protein-1, MTTP, microsomal triglyceride transfer protein, NF-κB, nuclear factor-κB, PL, phospholipid, RT-PCR, real-time PCR, SAA, serum amyloid A, Srebp-1c, sterol-regulatory element binding protein, TC, total cholesterol, TG, triglyceride, TNFα, tumor necrosis factor α, VLDL, very-low-density lipoprotein

Keywords: NF-κB, Atherosclerosis, Mouse models, Liver, Hepatocyte, Inflammation, Lipid metabolism

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(11)00578-8

doi:10.1016/j.atherosclerosis.2011.06.055

Atherosclerosis
Volume 220, Issue 2 , Pages 362-368, February 2012